Monographie - Colistin mesilate sodium

Utolsó frissítés :
19/11/2024

Colistin mesilate sodium

Kémiai szerkezet

Kereskedelmi név

A kereskedelmi név meghatározó jelentőségű: a készítmények összetétele országonként, előállítóként eltérő lehet

Alfacolin	Argentína
Alficetin	Argentína
Colent	Chile
Colimicina	Olaszország, Spanyolország
Colimycin	Dánia, Norvégia, Törökország
Colimycine	Franciaország, Hollandia, Luxemburg, Marokkó, Tunézia
Colismet	Peru
Colisti Ject	Egyiptom
Colistimetal sodic	Románia
Colistimetato de sodio	Chile, Peru, Spanyolország
Colistimethate	Amerikai Egyesült Államok, Kanada, Nagy-Britannia
Colistin	Ausztria, Görögország, Lengyelország, új-Zéland
Colistina	Argentína, Portugália
Colistineb	Belgium
Colistyn	Argentína
Colixin	Portugália
Colomycin	Amerikai Egyesült Államok, Írország, Kanada, Malaysia, Nagy-Britannia
Coly-Mycin	Amerikai Egyesült Államok, Ausztrália
Cotrelan	Argentína
Dicupal	Chile
Elistin	Peru
Kolisod	Törökország
Nolisin	Argentína
Promixin	Írország, Nagy-Britannia, Norvégia
Toliscrin	Argentína

Irodalom : Colistin mesilate sodium

	Type	publikáció
1201	Napló	Yuhas EM, Lofton FT, Rosenberg HA, Mayron D, Baldinus JG. Cimetidine hydrochloride compatibility III: Room temperature stability in drug admixtures. Am J Hosp Pharm 1981 ; 38: 1919-1922.
2285	Napló	Wallace SJ, Li J, Rayner CR, Coulthard K, Nation RL. Stability of colistin methanesulfonate in pharmaceutical products and solutions for administration to patients. Antimicrob Agents Chemother 2008 ; 52, 9: 3047-3051.
2550	Napló	Roberts GW, Rossi S.O.P. Compatibility of nebulizer solutions Aust J Hosp Pharm 1993 ; 23: 35-37.
2783	Napló	Abdulla A,.van Leeuwen R.W.F, de Vries Schultink A.H.M,.Koch B.C.P. Stability of colistimethate sodium in a disposable elastomeric infusion device. Int J Pharm 2015 ; 486; 1-2: 367-369.
3254	Napló	Housman S.T, Tessier P.R, Nicolau D.P, Kuti J.L. Physical compatibility of telavancin hydrochloride with select i.v. drugs during simulated Y-site administration Am J Health-Syst Pharm 2011 ; 68: 2265-2270.
3360	Napló	Healan A. M, Gray W, Fuchs E.J, Griffiss J.M, Salata R.A, Blumer J. Stability of Colistimethate Sodium in Aqueous Solution. Antimicrob Agents Chemother 2012 ; 56:6432-6433.
3674	Laboratórium	Erythromycin lactobionate - Summary of Product Characteristics PanPharma 2016
3827	poszter	Ghazi I.M, Hamada Y, Nicolau D.P. Compatibility of tedizolid phosphate with selected intravenous drugs via simulated Y-site conditions. ASHP Midyear 2015
3828	poszter	Thabit A.K, Hamada Y, Nicolau D.P. Ceftozolane/tazobactam physical compatibility during simulated Y-site administration. ASHP Midyear 2015
3829	poszter	So W, Kim L, Thabit A.K, Nicolau D.P, Kuti J.L. Compatibility of isavunazonium sulfate during simulated Y-site administration. ASHP Midyear 2015
3997	Napló	Katip W. Visual compatibility of colistin injection with other antibiotics during simulated Y-site administration. Am J Health-Syst Pharm 2017 ; 74:14 : 1099-1102
4055	Napló	Monogue M, Almarzoky Abuhussain S, Kuti J, Nicolau D. Physical compatibility of fosfomycin for injection with select i.v. drugs during simulated Y-site administration. Am J Health-Syst Pharm 2018 , 75, 1:36-44
4145	Napló	Asempa T.E, Avery L.M, Kidd J.M, Kuti J.L, Nicolau D.P. Physical compatibility of plazomicin with select i.v. drugs during simulated Y-site administration. Am J Health-Syst Pharm 2018 ;75,14:1048-1056
4178	Napló	Post T.E, Kamerling I, van Rossen R, Burggraaf J, Stevens J, Dijkmans A, Heijerman H, Touw D, van Velzen A, Wilms E. Colistin methanesulfonate infusion solutions are stable over time and suitable for home administration. EJHP 2017 ; 25, e2
4319	Napló	Lessard J-J, Caron E, Schérer H, Forest J-M, Leclair G. Compatibility of Y-site Injection of Meropenem Trihydrate With 101 Other Injectable Drugs. Hosp Pharm 2020 ; 55, 5: 332-337.
4434	Napló	Avery L.M, Chen, I.H, Reyes, S, Nicolau, D.P, Kuti J.L. Assessment of the Physical Compatibility of Eravacycline and Common Parenteral Drugs During Simulated Y-site Administration. Clin Ther 2019 ; 41, 10: 2162-2170.
4438	Napló	Stawny M, Gostyńska A, Nadolna M, Jelińska A. Safe Practice of Y-Site Drug Administration: The Case of Colistin and Parenteral Nutrition Pharmaceutics 2020 ; 12: 292
4528	Napló	Lu J, Liu Q, Kupiec T, Vail H, Lunch L, Fam D, Vu N. Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration. Int J Pharm Compound 2021 ;25,1:52-61
4801	Napló	Ruiz V, Yuwei Shen Y, Abouelhassan Y, Fouad A, Nicolau D, Kuti J. Physical compatibility of sulbactam/durlobactam with select intravenous drugs during simulated Y-site administration. Am J Health-Syst Pharm 2024 ;51,1:

Mentions Légales